RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Applied BioCode Stock

Applied BioCode ROCE 2024

Applied BioCode ROCE

-0.28

Ticker

6598.TW

ISIN

KYG0488D1051

In 2024, Applied BioCode's return on capital employed (ROCE) was -0.28, a 19.68% increase from the -0.24 ROCE in the previous year.

Applied BioCode Aktienanalyse

What does Applied BioCode do?

Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Applied BioCode's Return on Capital Employed (ROCE)

Applied BioCode's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Applied BioCode's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Applied BioCode's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Applied BioCode’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Applied BioCode stock

What is the ROCE (Return on Capital Employed) of Applied BioCode this year?

The ROCE of Applied BioCode is -0.28 undefined this year.

How has the ROCE (Return on Capital Employed) of Applied BioCode developed compared to the previous year?

The ROCE of Applied BioCode has increased by 19.68% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Applied BioCode?

A high Return on Capital Employed (ROCE) indicates that Applied BioCode has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Applied BioCode?

A low ROCE (Return on Capital Employed) can indicate that Applied BioCode has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Applied BioCode impact the company?

An increase in the ROCE of Applied BioCode can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Applied BioCode affect the company?

A decrease in ROCE of Applied BioCode can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Applied BioCode?

Some factors that can affect Applied BioCode's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Applied BioCode so important for investors?

The ROCE of Applied BioCode is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Applied BioCode take to improve the ROCE?

To improve the ROCE, Applied BioCode can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Applied BioCode pay?

Over the past 12 months, Applied BioCode paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Applied BioCode is expected to pay a dividend of 0 TWD.

What is the dividend yield of Applied BioCode?

The current dividend yield of Applied BioCode is .

When does Applied BioCode pay dividends?

Applied BioCode pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Applied BioCode?

Applied BioCode paid dividends every year for the past 0 years.

What is the dividend of Applied BioCode?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Applied BioCode located?

Applied BioCode is assigned to the 'Health' sector.

Wann musste ich die Aktien von Applied BioCode kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Applied BioCode from 9/24/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.

When did Applied BioCode pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Applied BioCode in the year 2023?

In the year 2023, Applied BioCode distributed 0 TWD as dividends.

In which currency does Applied BioCode pay out the dividend?

The dividends of Applied BioCode are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Applied BioCode

Our stock analysis for Applied BioCode Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Applied BioCode Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.